MARC HOROWITZ to Soft Tissue Neoplasms
This is a "connection" page, showing publications MARC HOROWITZ has written about Soft Tissue Neoplasms.
Connection Strength
0.404
-
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer. 1996 Aug 15; 78(4):901-11.
Score: 0.119
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.115
-
Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institution. J Clin Oncol. 1986 Apr; 4(4):559-64.
Score: 0.058
-
Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors. Ann Thorac Surg. 1995 Jun; 59(6):1385-9; discussion 1390.
Score: 0.027
-
Atypical cytogenic aberrations in two childhood peripheral primitive neuroectodermal tumors. Genes Chromosomes Cancer. 1995 Feb; 12(2):142-7.
Score: 0.027
-
Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosomes Cancer. 1992 Nov; 5(4):299-310.
Score: 0.023
-
Intensive combined modality therapy of small round cell and undifferentiated sarcomas in children and young adults: local control and patterns of failure. Radiother Oncol. 1989 Nov; 16(3):189-201.
Score: 0.019
-
Challenges in the treatment of childhood fibromatosis. Arch Surg. 1987 Nov; 122(11):1296-8.
Score: 0.016